On Chinese-English Translation Strategies of Biopharmaceutical Corporate Profiles Guided by Adaptation Theory

Abstract

With the closer economic ties between countries and the spread of epidemics such as COVID-19, Chinese pharmaceutical enterprises have a potential international market. The quality of the English translation of pharmaceutical company profiles is of great significance to the development of international market and human health. Compared with 8 Chinese and 8 English pharmaceutical company profiles, there are significant different focuses. Besides the basic information, Chinese pharmaceutical company profiles stress the history and awards of the companies, while English pharmaceutical company profiles are centered on the effective information. The existing C-E translation problems lie in word-for-word translation, lack of logic between sentences or text and redundancy. Guided by adaptation theory, the following conclusions are drawn: on syntax level, when translating, the translator should apply the methods of creative translation, clarify the logical relationship between clauses, adjust the word order of sentences and appropriately add logical conjunctions. On discourse level, the translator can use creative translation— recompose the information of the profiles. Besides, we should emphasize the company’s care for life and health. Only in this way can contextual relations and linguistic structure be adapted. I hope it will be helpful to the English translation of the profiles of Chinese pharmaceutical enterprises.